Current treatment patterns and medical costs for multiple myeloma in Japan: a cross-sectional analysis of a health insurance claims database

Medicine & Life Sciences

• Costs and Cost Analysis 41%
• Cross-Sectional Studies 43%
• Databases 40%
• Drug Costs 20%
• Health Insurance 69%
• International Classification of Diseases 5%
• Japan 54%
• Lenalidomide 7%
• Multiple Myeloma 65%
• Names 5%
• Pharmaceutical Preparations 16%
• Therapeutics 10%

Social Sciences

• acute care hospitals 20%
• costs 37%
• drug 45%
• health insurance 68%
• hospitalization 7%
• insurance claim 100%
• International Classification 8%
• Japan 48%
• medical data 9%
• surgery 6%